Switch theme
Sign up to access all valuation multiples
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
1994
336
LTM Revenue $236M
LTM EBITDA $21.8M
$546M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
LifeMD has a last 12-month revenue (LTM) of $236M and a last 12-month EBITDA of $21.8M.
In the most recent fiscal year, LifeMD achieved revenue of $212M and an EBITDA of -$6.7M.
LifeMD expects next 12-month revenue of XXX and NTM EBITDA of XXX
See LifeMD valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $236M | XXX | $212M | XXX | XXX | XXX |
| Gross Profit | $209M | XXX | $188M | XXX | XXX | XXX |
| Gross Margin | 88% | XXX | 89% | XXX | XXX | XXX |
| EBITDA | $21.8M | XXX | -$6.7M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | -3% | XXX | XXX | XXX |
| EBIT | -$6.6M | XXX | -$16.1M | XXX | XXX | XXX |
| EBIT Margin | -3% | XXX | -8% | XXX | XXX | XXX |
| Net Profit | -$10.7M | XXX | -$18.9M | XXX | XXX | XXX |
| Net Margin | -5% | XXX | -9% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, LifeMD's stock price is $12.
LifeMD has current market cap of $555M, and EV of $546M.
See LifeMD trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $546M | $555M | XXX | XXX | XXX | XXX | $-0.31 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, LifeMD has market cap of $555M and EV of $546M.
LifeMD's trades at 2.6x EV/Revenue multiple, and -82.1x EV/EBITDA.
Equity research analysts estimate LifeMD's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
LifeMD has a P/E ratio of -52.1x.
See valuation multiples for LifeMD and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $555M | XXX | $555M | XXX | XXX | XXX |
| EV (current) | $546M | XXX | $546M | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.6x | XXX | XXX | XXX |
| EV/EBITDA | 25.0x | XXX | -82.1x | XXX | XXX | XXX |
| EV/EBIT | -82.2x | XXX | -33.8x | XXX | XXX | XXX |
| EV/Gross Profit | 2.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | -52.1x | XXX | -29.4x | XXX | XXX | XXX |
| EV/FCF | 64.6x | XXX | 91.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLifeMD's last 12 month revenue growth is 22%
LifeMD's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.6M for the same period.
LifeMD's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
LifeMD's rule of X is 65% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for LifeMD and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 22% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | -3% | XXX | XXX | XXX |
| EBITDA Growth | 71% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 17% | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 65% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 48% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 96% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| UniDoc Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Ping An Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Kooth | XXX | XXX | XXX | XXX | XXX | XXX |
| Atrys Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
LifeMD acquired XXX companies to date.
Last acquisition by LifeMD was XXXXXXXX, XXXXX XXXXX XXXXXX . LifeMD acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was LifeMD founded? | LifeMD was founded in 1994. |
| Where is LifeMD headquartered? | LifeMD is headquartered in United States of America. |
| How many employees does LifeMD have? | As of today, LifeMD has 336 employees. |
| Who is the CEO of LifeMD? | LifeMD's CEO is Mr. Justin Schreiber. |
| Is LifeMD publicy listed? | Yes, LifeMD is a public company listed on NAS. |
| What is the stock symbol of LifeMD? | LifeMD trades under LFMD ticker. |
| When did LifeMD go public? | LifeMD went public in 2020. |
| Who are competitors of LifeMD? | Similar companies to LifeMD include e.g. Doctor Care Anywhere, UniDoc Health, Ping An Healthcare, Kooth. |
| What is the current market cap of LifeMD? | LifeMD's current market cap is $555M |
| What is the current revenue of LifeMD? | LifeMD's last 12 months revenue is $236M. |
| What is the current revenue growth of LifeMD? | LifeMD revenue growth (NTM/LTM) is 22%. |
| What is the current EV/Revenue multiple of LifeMD? | Current revenue multiple of LifeMD is 2.3x. |
| Is LifeMD profitable? | Yes, LifeMD is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of LifeMD? | LifeMD's last 12 months EBITDA is $21.8M. |
| What is LifeMD's EBITDA margin? | LifeMD's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of LifeMD? | Current EBITDA multiple of LifeMD is 25.0x. |
| What is the current FCF of LifeMD? | LifeMD's last 12 months FCF is $8.5M. |
| What is LifeMD's FCF margin? | LifeMD's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of LifeMD? | Current FCF multiple of LifeMD is 64.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
